In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: AION Labs: At the forefront of the pharmaceutical revolution
AION Labs: At the forefront of the pharmaceutical revolution
The Jerusalem Post
Four times a year, five teams of scientists are invited to Israel for a five-day intensive boot camp, during which they solve a challenge relevant to today’s pharma industry.
Visit: Israel’s AION Labs Lanches Third Call For Proposals To Develop Antibody Therapies
Israel’s AION Labs Lanches Third Call For Proposals To Develop Antibody Therapies
nocamels
Israeli-headquartered, AION Labs, and German independent research institute, BioMed X, this week announced their third global call for biomedical scientists and interested investors to apply for a new AION Labs startup in Rehovot focused on “AI-enabled design and optimization of antibodies for targeted therapies”.
Visit: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies
AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies
AITHORITY
AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X, announced the launch of the third global call for application to identify biomedical scientists and inventors to form a new startup at AION Labs’ headquarters in Rehovot, Israel.
Visit: BioMed X institute and Merck KGaA extend cancer collaboration
BioMed X institute and Merck KGaA extend cancer collaboration
thepharmaletter
German independent research institute BioMed X says it has extended its collaboration with Merck KGaA, Darmstadt, Germany.